LCS
Levin Capital Strategies Portfolio holdings
AUM
$1.02B
This Quarter Return
-15.75%
1 Year Return
+24.33%
3 Year Return
+82.04%
5 Year Return
+153.74%
10 Year Return
+220.71%
AUM
$4.54B
AUM Growth
+$4.54B
(-22%)
Cap. Flow
-$447M
Cap. Flow
% of AUM
-9.84%
Top 10 Holdings %
Top 10 Hldgs %
42.65%
Holding
327
New
47
Increased
53
Reduced
101
Closed
69
Top Buys
1 |
Bio-Rad Laboratories Class A
BIO
|
$130M |
2 |
Quest Diagnostics
DGX
|
$120M |
3 |
CommScope
COMM
|
$73.9M |
4 |
Textron
TXT
|
$66.4M |
5 |
CVS Health
CVS
|
$63.2M |
Top Sells
1 |
Merck
MRK
|
$166M |
2 |
Nokia
NOK
|
$116M |
3 |
General Dynamics
GD
|
$93.3M |
4 |
Pfizer
PFE
|
$88M |
5 |
Intel
INTC
|
$87.6M |
Sector Composition
1 | Financials | 19% |
2 | Healthcare | 14.48% |
3 | Technology | 13.52% |
4 | Consumer Discretionary | 10.91% |
5 | Consumer Staples | 10.32% |